Turner & Townsend lands GSK Montrose portfolio management role

Turner & Townsend lands GSK Montrose portfolio management role.

Turner & Townsend has been appointed to support GlaxoSmithKline’s capital portfolio management in Montrose, Scotland. 

As part of Turner & Townsend’s growing capability across its real estate team in Scotland, the appointment includes complete portfolio management of GSK’s key manufacturing facilities in Montrose.

The professional services firm will provide concept/feasibility project management, as well as project controls (cost and planning) for the portfolio. 

As a global supplier to GSK, Turner & Townsend is already providing a full range of services including project and programme management, cost management and projects controls services both globally and UK-wide. 

Adding to this existing partnership, Turner & Townsend will be increasing its coverage even further to support GSK’s ongoing capital investment into the Montrose site, to secure longevity of the site and support continuous improvement of its production line and office facilities. 

Daniel Boreham, director of life sciences at Turner & Townsend, said: “This appointment strengthens our long-standing relationship with GSK, whilst providing opportunity to venture into a new region and bring some of our global initiatives such as the benchmarking club which brings GSK together with other major pharmaceutical companies to share data and best practice from across the industry to improve project delivery. 

“This commission with GSK, combined with our existing wealth of expertise in the life sciences sector both globally and across the UK, puts us in good stead to taking this next step into the Scottish regions, where we have great ambitions for the industry."

If you would like to contact Karen McLauchlan about this, or any other story, please email